US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist
  • 0.692
  • -0.023-3.25%
Close Apr 18 16:00 ET
  • 0.730
  • +0.038+5.54%
Post 19:46 ET
82.56MMarket Cap-265P/E (TTM)

About Atara Biotherapeutics Company

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Company Profile

SymbolATRA
Company NameAtara Biotherapeutics
Listing DateOct 16, 2014
Issue Price11.00
Founded2012
CEODr. Pascal Touchon, D.V.M.
MarketNASDAQ
Employees225
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address2380 Conejo Spectrum Street,Suite 200
CityThousand Oaks
ProvinceCalifornia
CountryUnited States of America
Zip Code91320
Phone1-805-623-4211
Websitehttp://www.atarabio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Pascal Touchon, D.V.M.
  • Director, President and Chief Executive Officer
  • 5.16M
  • Eric Hyllengren
  • Senior Vice President, Chief Financial Officer and Principal Accounting Officer
  • --
  • Cokey Nguyen
  • Chief Scientific Officer
  • --
  • Amar Murugan
  • Executive Vice President and Chief Legal Officer
  • 1.79M
  • Dr. Carol G. Gallagher,Pharm.D.
  • Chairman of the Board
  • 357.85K
  • Matthew K. Fust
  • Independent Director
  • 370.35K
  • William K. Heiden
  • Independent Director
  • 355.35K
  • Dr. Maria Grazia Roncarolo, M.D.
  • Independent Director
  • 345.35K
  • Eric L. Dobmeier
  • Independent Director
  • 370.35K
  • Ameet Mallik
  • Independent Director
  • 345.35K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg